SynthesisNeuro-oncology2023

Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival.

Benjamin M Ellingson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.